SJP 101
Alternative Names: SJP-101Latest Information Update: 03 Mar 2023
At a glance
- Originator Sen Jam Pharmaceutical
- Class Drug withdrawal therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Opioid-related disorders
Most Recent Events
- 15 Feb 2023 Preclinical trials in Opioid-related disorders in USA (Parenteral) (Sen Jam Pharmaceutical pipeline, February 2023)